Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedLocations were reorganized into a single 'Locations' section listing California, Minnesota, New Jersey, and Texas, replacing the prior state-specific subsections. A new revision tag v3.3.3 was added.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision history updated: added Revision v3.3.2 and removed Revision v3.2.0.SummaryDifference0.0%

- Check46 days agoChange DetectedRemoved the general government funding lapse notice from the page; the previous notice warned that information may not be up to date and directed users to cc.nih.gov and opm.gov.SummaryDifference0.3%

- Check67 days agoChange DetectedCore study content remains unchanged between screenshots; any visible differences are limited to formatting or layout rather than study details. No additions or deletions affecting the trial information were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check89 days agoChange DetectedUpdated operational notice and version to v3.2.0; removed two cancer-type items (Cutaneous neuroendocrine carcinoma, Small cell lung carcinoma) and prior version tag v3.1.0; added links to status pages.SummaryDifference3%

- Check96 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.